With the growth strategy in the healthcare sector stagnating, a change of representative director was decided. The new Representative Director will be Tatsuya Saka (Representative Director of medical corporations, etc.), and the current Representative Director will resign and become a director. The change will take effect on September 17, 2026, with no impact on the consolidated results for the fiscal year ending September 2026.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"3624","jir_company_name":"Axel Mark Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-09-17","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/09\/3624-20260917-01.pdf","jir_short_summary":"With the growth strategy in the healthcare sector stagnating, a change of representative director was decided. The new Representative Director will be Tatsuya Saka (Representative Director of medical corporations, etc.), and the current Representative Director will resign and become a director. The change will take effect on September 17, 2026, with no impact on the consolidated results for the fiscal year ending September 2026.","jir_summary":"### Section Heading\nThis release reports the transition to a new management structure through the change of Representative Director, set against a backdrop of prolonged operating losses and stagnation in the growth strategy within the healthcare sector. The new Representative Director is appointed as Tatsuya Saka, with plans to rebuild the healthcare sector, including the existing Beauty & Wellness business, and to promote business investment. The current Representative Director, Hirofumi Matsukawa, will resign and participate in management as a director. The change will take effect on September 17, 2026.\n\n### Section 2 Heading\nLooking ahead, the company states that the change will not directly affect the consolidated results for the fiscal year ending September 2026, and that rebuilding the growth strategy in the healthcare sector and achieving profitability in existing businesses may require a considerable period. The specific execution plans under the new structure and market reaction are uncertain, and the company will strive to restore the trust of shareholders and stakeholders with full effort.","jir_financial_highlights":"Impact on consolidated results: Unknown (Unknown)\nChange date: September 17, 2026 (Unknown)","jir_category":"","jir_hashtags":"#AxelMark, #ChangeOfRepresentativeDirector, #HealthcareStrategy, #ManagementBoardRefresh","jir_key_figures":"Change date: September 17, 2026\nNew Representative Director: Tatsuya Saka (Representative Director of Medical Corporation Shikij\u014dkai)\nCurrent position change: Hirofumi Matsukawa, President & Representative Director \u2192 Director","jir_meta_title":"Axel Mark: Announcement of Change in Representative Director | September 17, 2026","jir_meta_description":"Axel Mark resolved the change of Representative Director at the Board. The new Representative Director, Tatsuya Saka, will leverage his medical and management experience to rebuild the healthcare sector. The current representative will become a director. Dated September 17, 2026.","jir_og_title":"Axel Mark: Announcement of Change in Representative Director | September 17, 2026","jir_og_description":"Announcement of a change in Representative Director aimed at rebuilding the healthcare sector. Summary of growth strategy under the new regime, current challenges, and future outlook.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":61293,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"executive_change","footnotes":""},"sector":[],"importance":[],"class_list":["post-114802","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n